000 01621 a2200385 4500
005 20250515062431.0
264 0 _c20070612
008 200706s 0 0 ger d
022 _a0941-293X
024 7 _a10.1007/s00347-007-1514-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHöh, A E
245 0 0 _a[Central and branch retinal vein occlusion. Current strategies for treatment in Germany, Austria and Switzerland].
_h[electronic resource]
260 _bDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
_cApr 2007
300 _a290-4 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article
650 0 4 _aAngiogenesis Inhibitors
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aAustria
_xepidemiology
650 0 4 _aBevacizumab
650 0 4 _aDelivery of Health Care
_xstatistics & numerical data
650 0 4 _aGermany
_xepidemiology
650 0 4 _aHemodilution
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aLight Coagulation
_xstatistics & numerical data
650 0 4 _aPractice Patterns, Physicians'
_xstatistics & numerical data
650 0 4 _aRetinal Vein Occlusion
_xepidemiology
650 0 4 _aSurveys and Questionnaires
650 0 4 _aSwitzerland
_xepidemiology
700 1 _aSchaal, K B
700 1 _aDithmar, S
773 0 _tDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
_gvol. 104
_gno. 4
_gp. 290-4
856 4 0 _uhttps://doi.org/10.1007/s00347-007-1514-0
_zAvailable from publisher's website
999 _c16941678
_d16941678